Features

Latest Features

Investigators compared recurrence-free survival and overall survival outcomes in patients randomly assigned to receive neoadjuvant talimogene laherparepvec (T-VEC) followed by immediate surgery or surgery alone.

Skin Cancer

T-VEC Shows Promise as Neoadjuvant Therapy in Melanoma

By

Victoria Forster, PhD

Eggs, milk and nuts

General Dermatology

AAAAI/ACAAI/CSACI Consensus Statement on Infant Food Allergy Prevention

By

Brandon May

“‘Trended strongly’ is code for ‘we failed to meet statistical significance,’” remarked one expert, when she was asked to scrutinize the conclusions of a recent post hoc analysis.

Skin Cancer

A Statistical Fallacy Might Mar Study Findings on Bevacizumab in Melanoma

By

Agata Boxe

Psoriasis

Multifactorial Etiologies and Comorbidities of Psoriasis Yield Clues to Treatment

By

Linda Peckel

African American black woman female patient with White doctor

General Dermatology

Expert Roundtable: Racial Disparities in Dermatology Care

By

Tori Rodriguez, MA, LPC, AHC

Skin Cancer

How Do Melanoma Comorbidities Affect Patient Treatment Preferences?

By

Steve Fiorillo

Observational study design and conflicts of interest prevent researchers from determining whether the FDA-mandated black box warning is warranted.

Skin Cancer

Industry-Funded Study Suggests There Is No Association Between TCI Use and Increased Skin Cancer Risk in Atopic Dermatitis

By

Agata Boxe

Patients given prophylactic treatment were 94% less likely to require a first rescue treatment for rash and 74% less likely to require a second rescue treatment.

Skin Cancer

Skin Toxicity Program Can Positively Address EGFR Inhibitor-Related Skin Toxicities

By

Leah Lawrence

COVID doctor prescribing

Infections

Dermatologic Challenges to Preventing Antimicrobial Resistance During the COVID-19 Pandemic

By

Linda Peckel

General Dermatology

The Appearance of Skin Disorders Often Predicts Diabetes

By

Linda Peckel